Table 2 Patients’ clinical and biological features at time of blood sampling

n

33

20

Age (Y), mean (range)

63 (50–82)

59 (33–79)

Gender (F/M)

16/17

11/9

MPO-ANCA titer (median, range)

87.44 (28.48–164.5)

BVAS (mean, range)

19(15–27)

White blood cells (10⁹/l) (mean, SD)

7.52±3.05

Hemoglobin (g/l) (mean, SD)

71.82±16.84

Platelet (10⁹/l) (mean, SD)

240.58±68.26

Neutrophil (10⁹/l) (mean, SD)

5.65±2.87

Neutrophil percentage (%) (mean, SD)

73.67±10.43

Lymphocyte (10⁹/l) (mean, SD)

1.08±0.65

Lymphocyte percentage (%) (mean, SD)

15.71±8.88

CRP (mg/L) (median range)

37.2 (1.45–253)

ESR (mm/h) (median range)

95 (2–120)

 ENT

2 (6%)

 Eyes

2 (6%)

 Pulmonary

31 (94%)

 Gastrointestinal

17 (52%)

 Nervous system

1 (3%)

Renal

33 (100%)

 Proteinuria, n (%)

31 (94%)

 Proteinuria(g/day) (median range)

1.6 (0.48–6.87)

 Heterogeneous hematuria, n (%)

30 (97%)

 Renal insufficiency, n (%)

33 (100%)

 Serum creatine(umol/L) (median range)

628 (124–1395)

 eGFR (ml/min*1.73 m2) (median range)

6.3 (2.3–58)

 Subjects, no.

14

 Focal

1 (7.1%)

 Mixed

2 (14.3%)

 Crescentic

8 (57.1%)

 Sclerotic

3 (21.4%)